These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38802436)

  • 1. First external validity study of the Fagotti score in ovarian cancer.
    Sarah A; Mathieu L; Henri A; Marcos B; Geoffroy C; Pauline C; Tristan G; Cyrille H; Yohan K; Martin K; Lise L; Lobna O; Émilie R; Vincent L; Guillaume L
    Sci Rep; 2024 May; 14(1):12133. PubMed ID: 38802436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.
    Fleming ND; Westin SN; Meyer LA; Shafer A; Rauh-Hain JA; Onstad M; Cobb L; Bevers M; Fellman BM; Burzawa J; Bhosale P; Zand B; Jazaeri A; Levenback C; Coleman RL; Soliman PT; Sood AK
    Int J Gynecol Cancer; 2021 Jan; 31(1):92-97. PubMed ID: 33154095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bendifallah S; Body G; Daraï E; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.
    Brun JL; Rouzier R; Uzan S; Daraï E
    Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer.
    Angeles MA; Migliorelli F; Del M; Martínez-Gómez C; Daix M; Bétrian S; Gabiache E; Balagué G; Leclerc S; Mery E; Gladieff L; Ferron G; Martinez A
    Arch Gynecol Obstet; 2021 May; 303(5):1295-1304. PubMed ID: 33389113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.
    Varnoux C; Huchon C; Bats AS; Bensaid C; Achouri A; Nos C; Lécuru F
    Eur J Surg Oncol; 2013 Jul; 39(7):774-9. PubMed ID: 23597496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer.
    Kim NY; Jung DC; Lee JY; Han KH; Oh YT
    Korean J Radiol; 2021 Sep; 22(9):1481-1489. PubMed ID: 34132077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer.
    Saner FAM; Ruggeri G; Siegenthaler F; Wampfler J; Imboden S; Mueller MD
    Int J Gynecol Cancer; 2023 Oct; 33(10):1595-1601. PubMed ID: 37567597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
    Moruzzi MC; Bolomini G; Esposito R; Mascilini F; Ciccarone F; Quagliozzi L; Giudice MT; Beneduce G; Ficarelli S; Moroni R; Scambia G; Fagotti A; Testa AC; Moro F
    Am J Obstet Gynecol; 2022 Oct; 227(4):601.e1-601.e20. PubMed ID: 35752305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study.
    Tomar TS; Nair RP; Sambasivan S; Krishna KMJ; Mathew A; Ahmed IM
    Indian J Cancer; 2017; 54(3):550-555. PubMed ID: 29798957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.
    Hansen JM; Sood AK; Coleman RL; Westin SN; Soliman PT; Ramirez PT; Fellman BM; Schmeler KM; Fleming ND
    Gynecol Oncol; 2018 Dec; 151(3):428-432. PubMed ID: 30366647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of non-resectability using the updated Predictive Index Value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.
    Moro F; Pinto AP; Chiappa V; Testa AC; Alcázar JL; Franchi D; Benesova K; Jarkovsky J; Fruhauf F; Borčinová M; Burgetova A; Masek M; Lambert L; Altmanova D; Avesani G; Panico C; Alessi S; Pricolo P; Vara García J; Palladino S; Vigorito R; Calareso G; Kocian R; Slama J; Vidal Urbinati AM; Raspagliesi F; Fagotti A; Scambia G; Cibula D; Fischerová D
    Am J Obstet Gynecol; 2024 Jul; ():. PubMed ID: 38969200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery.
    Chereau E; Lavoue V; Ballester M; Coutant C; Selle F; Cortez A; Daraï E; Leveque J; Rouzier R
    Anticancer Res; 2011 Dec; 31(12):4469-74. PubMed ID: 22199317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Ferron G; Narducci F; Pouget N; Touboul C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer.
    Llueca A; Climent MT; Escrig J; Carrasco P; Serra A;
    Sci Rep; 2021 Apr; 11(1):8111. PubMed ID: 33854085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
    Chéreau E; Ballester M; Selle F; Cortez A; Daraï E; Rouzier R
    Am J Obstet Gynecol; 2010 Feb; 202(2):178.e1-178.e10. PubMed ID: 20113693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study).
    Pomel C; Akladios C; Lambaudie E; Rouzier R; Ferron G; Lecuru F; Classe JM; Fourchotte V; Paillocher N; Wattiez A; Montoriol PF; Thivat E; Beguinot M; Canis M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1572-1578. PubMed ID: 34670829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Tang X; Zhang X; Liu X; Zheng T; Hua K; Qiu J
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():256-262. PubMed ID: 33259994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Bull Cancer; 2019 Apr; 106(4):354-370. PubMed ID: 30850152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.